[Form 4] Eli Lilly & Co. Insider Trading Activity
Mary Lynne Hedley, a director of Eli Lilly & Co. (LLY), reported a transaction on 08/18/2025 in which shares were acquired under the companys director deferral arrangements. The filing shows an acquisition (Code A) of 14.206 units at a reported price of $698.05. The report lists 1,986.78 shares beneficially owned following the transaction, with ownership reported as direct and indirect (by trust) where applicable. The filing explains the shares were deferred in lieu of cash compensation as stock units under the Lilly Directors Deferral Plan and will be settled in common stock after the reporting persons separation from service. The reporting person disclaims beneficial ownership except to the extent of pecuniary interest.
Mary Lynne Hedley, membro del consiglio di amministrazione di Eli Lilly & Co. (LLY), ha comunicato una transazione avvenuta il 18/08/2025 in cui sono state acquisite azioni nell鈥檃mbito dei piani di rinvio compensi per amministratori della societ脿. La comunicazione indica un acquisto (Codice A) di 14.206 unit脿 al prezzo riportato di $698.05. Dopo la transazione risultano detenute beneficiariamente 1,986.78 azioni, con la titolarit脿 segnalata come diretta e, ove applicabile, indiretta (tramite trust). Il documento spiega che le azioni sono state differite in luogo del compenso in contanti come unit脿 azionarie ai sensi del Lilly Directors-Deferral Plan e saranno convertite in azioni ordinarie al momento della cessazione del rapporto di servizio della persona che ha effettuato la segnalazione. La persona che ha presentato la segnalazione dichiara di non avere la propriet脿 beneficiaria, salvo per l鈥檌nteresse pecuniario.
Mary Lynne Hedley, directora de Eli Lilly & Co. (LLY), notific贸 una operaci贸n el 18/08/2025 en la que se adquirieron acciones bajo los planes de aplazamiento para directores de la compa帽铆a. La presentaci贸n registra una adquisici贸n (C贸digo A) de 14.206 unidades a un precio informado de $698.05. Tras la operaci贸n se indican 1,986.78 acciones en propiedad beneficiaria, con la titularidad declarada como directa y, cuando procede, indirecta (a trav茅s de un fideicomiso). El documento aclara que las acciones se aplazaron en lugar de la compensaci贸n en efectivo como unidades de acciones seg煤n el Lilly Directors-Deferral Plan y se liquidar谩n en acciones ordinarias tras la separaci贸n de la persona informante del servicio. La persona que informa renuncia a la propiedad beneficiaria salvo en la medida de su inter茅s pecuniario.
Eli Lilly & Co.(LLY) 鞚挫偓須� 鞚挫偓鞚� Mary Lynne Hedley電� 2025雲� 8鞗� 18鞚� 須岇偓鞚� 鞚挫偓 氤挫垬 鞚挫棸 鞝滊弰鞐� 霐半澕 欤检嫕鞚� 旆摑頃� 瓯半灅毳� 鞁犼碃頄堨姷雼堧嫟. 鞝滌稖靹滊電� 旆摑(旖旊摐 A)鞙茧 14.206 雼渼毳� 氤搓碃 臧�瓴� $698.05搿� 響滌嫓頃橁碃 鞛堨姷雼堧嫟. 瓯半灅 頉� 氤搓碃鞛愲姅 1,986.78欤检潣 靾橃澋鞝� 靻岇湢毳� 氤挫湢頃� 瓴冹溂搿� 旮办灛霅橃棃鞙茧┌, 靻岇湢 順曧儨電� 頃措嫻霅橂姅 瓴届毎 歆侅为 氚� 鞁犿儊鞚� 韱淀暅 臧勳爲鞙茧 氤搓碃霅橃棃鞀惦媹雼�. 靹滊鞐愲姅 頃措嫻 欤检嫕鞚� 順勱笀 氤挫垬 雽�鞁� Lilly Directors-Deferral Plan鞐� 霐半ジ 欤检嫕 雼渼搿� 鞚挫棸霅橃棃瓿�, 氤搓碃鞚胳澊 攴茧鞐愳劀 韲挫頃� 頉� 氤错喌欤茧 鞝曥偘霅� 瓴冹澊霛缄碃 靹る獏霅橃柎 鞛堨姷雼堧嫟. 氤搓碃鞚胳潃 鞛偘靸� 鞚挫澋鞚� 氩旍渼毳� 鞝滌櫢頃橁碃電� 靾橃澋鞝� 靻岇湢毳� 攵�鞚疙暕雼堧嫟.
Mary Lynne Hedley, administratrice d鈥橢li Lilly & Co. (LLY), a d茅clar茅 une transaction en date du 18/08/2025 au cours de laquelle des actions ont 茅t茅 acquises dans le cadre des dispositifs de report pour administrateurs de la soci茅t茅. Le d茅p么t indique une acquisition (Code A) de 14.206 unit茅s au prix d茅clar茅 de $698.05. Apr猫s la transaction, 1,986.78 actions sont d茅tenues 脿 titre b茅n茅ficiaire, la propri茅t茅 茅tant d茅clar茅e directe et, le cas 茅ch茅ant, indirecte (par trust). Le document pr茅cise que les actions ont 茅t茅 diff茅r茅es en lieu et place d鈥檜ne r茅mun茅ration en esp猫ces sous forme d鈥檜nit茅s d鈥檃ctions selon le Lilly Directors-Deferral Plan et seront r茅gl茅es en actions ordinaires apr猫s la cessation de service de la personne d茅clarante. La personne d茅clarante d茅cline la qualit茅 de propri茅taire b茅n茅ficiaire, sauf dans la mesure d鈥檜n int茅r锚t p茅cuniaire.
Mary Lynne Hedley, Direktorin von Eli Lilly & Co. (LLY), meldete am 18.08.2025 eine Transaktion, bei der Aktien im Rahmen der Director-Deferral-Vereinbarungen des Unternehmens erworben wurden. Die Meldung weist einen Erwerb (Code A) von 14.206 Einheiten zu einem gemeldeten Preis von $698.05 aus. Nach der Transaktion werden 1,986.78 Aktien als wirtschaftlich gehalten angegeben; die Eigent眉merschaft ist gegebenenfalls als direkt und indirekt (durch Trust) ausgewiesen. In der Meldung hei脽t es, dass die Aktien statt Barverg眉tung als Aktieneinheiten im Rahmen des Lilly Directors-Deferral Plan aufgeschoben wurden und nach dem Ausscheiden der meldenden Person aus dem Unternehmen in Stammaktien umgewandelt werden. Die meldende Person verneint die wirtschaftliche Eigent眉merschaft, soweit nicht ein pecuni盲rer Anspruch besteht.
- Director elected to defer compensation into stock units, which aligns director economic interests with shareholders as stated in the filing
- Clear disclosure of settlement terms (stock units to be settled in shares following separation) and ownership disclaimer
- None.
Insights
TL;DR: Routine director deferral into stock units; aligns compensation with equity without indicating a trading decision.
The Form 4 documents a common governance practice where a director elects to defer cash compensation into stock units under the company's Directors' Deferral Plan. The units are to be settled in shares following separation from service, which is explicitly stated in the filing. The reporting person also disclaims beneficial ownership beyond pecuniary interest, consistent with trustee arrangements. This filing shows 14.206 units acquired at $698.05 on 08/18/2025 and a post-transaction beneficial ownership figure of 1,986.78 shares. There is no indication of a sale, waiver, or other unusual governance event in the document.
TL;DR: Transaction appears administrative and non-material to company capital structure; no market-moving disposition reported.
The filing records an acquisition (code A) tied to compensation deferral rather than an open-market purchase. The price shown ($698.05) likely reflects an accounting unit value for the deferred stock units rather than an active market trade by the director. The report clarifies settlement timing (upon separation) and includes a standard disclaimer of beneficial ownership except for pecuniary interest. Based solely on the filing, there is no evidence of material change to insider holdings or of a trading intent that would be immediately material to investors.
Mary Lynne Hedley, membro del consiglio di amministrazione di Eli Lilly & Co. (LLY), ha comunicato una transazione avvenuta il 18/08/2025 in cui sono state acquisite azioni nell鈥檃mbito dei piani di rinvio compensi per amministratori della societ脿. La comunicazione indica un acquisto (Codice A) di 14.206 unit脿 al prezzo riportato di $698.05. Dopo la transazione risultano detenute beneficiariamente 1,986.78 azioni, con la titolarit脿 segnalata come diretta e, ove applicabile, indiretta (tramite trust). Il documento spiega che le azioni sono state differite in luogo del compenso in contanti come unit脿 azionarie ai sensi del Lilly Directors-Deferral Plan e saranno convertite in azioni ordinarie al momento della cessazione del rapporto di servizio della persona che ha effettuato la segnalazione. La persona che ha presentato la segnalazione dichiara di non avere la propriet脿 beneficiaria, salvo per l鈥檌nteresse pecuniario.
Mary Lynne Hedley, directora de Eli Lilly & Co. (LLY), notific贸 una operaci贸n el 18/08/2025 en la que se adquirieron acciones bajo los planes de aplazamiento para directores de la compa帽铆a. La presentaci贸n registra una adquisici贸n (C贸digo A) de 14.206 unidades a un precio informado de $698.05. Tras la operaci贸n se indican 1,986.78 acciones en propiedad beneficiaria, con la titularidad declarada como directa y, cuando procede, indirecta (a trav茅s de un fideicomiso). El documento aclara que las acciones se aplazaron en lugar de la compensaci贸n en efectivo como unidades de acciones seg煤n el Lilly Directors-Deferral Plan y se liquidar谩n en acciones ordinarias tras la separaci贸n de la persona informante del servicio. La persona que informa renuncia a la propiedad beneficiaria salvo en la medida de su inter茅s pecuniario.
Eli Lilly & Co.(LLY) 鞚挫偓須� 鞚挫偓鞚� Mary Lynne Hedley電� 2025雲� 8鞗� 18鞚� 須岇偓鞚� 鞚挫偓 氤挫垬 鞚挫棸 鞝滊弰鞐� 霐半澕 欤检嫕鞚� 旆摑頃� 瓯半灅毳� 鞁犼碃頄堨姷雼堧嫟. 鞝滌稖靹滊電� 旆摑(旖旊摐 A)鞙茧 14.206 雼渼毳� 氤搓碃 臧�瓴� $698.05搿� 響滌嫓頃橁碃 鞛堨姷雼堧嫟. 瓯半灅 頉� 氤搓碃鞛愲姅 1,986.78欤检潣 靾橃澋鞝� 靻岇湢毳� 氤挫湢頃� 瓴冹溂搿� 旮办灛霅橃棃鞙茧┌, 靻岇湢 順曧儨電� 頃措嫻霅橂姅 瓴届毎 歆侅为 氚� 鞁犿儊鞚� 韱淀暅 臧勳爲鞙茧 氤搓碃霅橃棃鞀惦媹雼�. 靹滊鞐愲姅 頃措嫻 欤检嫕鞚� 順勱笀 氤挫垬 雽�鞁� Lilly Directors-Deferral Plan鞐� 霐半ジ 欤检嫕 雼渼搿� 鞚挫棸霅橃棃瓿�, 氤搓碃鞚胳澊 攴茧鞐愳劀 韲挫頃� 頉� 氤错喌欤茧 鞝曥偘霅� 瓴冹澊霛缄碃 靹る獏霅橃柎 鞛堨姷雼堧嫟. 氤搓碃鞚胳潃 鞛偘靸� 鞚挫澋鞚� 氩旍渼毳� 鞝滌櫢頃橁碃電� 靾橃澋鞝� 靻岇湢毳� 攵�鞚疙暕雼堧嫟.
Mary Lynne Hedley, administratrice d鈥橢li Lilly & Co. (LLY), a d茅clar茅 une transaction en date du 18/08/2025 au cours de laquelle des actions ont 茅t茅 acquises dans le cadre des dispositifs de report pour administrateurs de la soci茅t茅. Le d茅p么t indique une acquisition (Code A) de 14.206 unit茅s au prix d茅clar茅 de $698.05. Apr猫s la transaction, 1,986.78 actions sont d茅tenues 脿 titre b茅n茅ficiaire, la propri茅t茅 茅tant d茅clar茅e directe et, le cas 茅ch茅ant, indirecte (par trust). Le document pr茅cise que les actions ont 茅t茅 diff茅r茅es en lieu et place d鈥檜ne r茅mun茅ration en esp猫ces sous forme d鈥檜nit茅s d鈥檃ctions selon le Lilly Directors-Deferral Plan et seront r茅gl茅es en actions ordinaires apr猫s la cessation de service de la personne d茅clarante. La personne d茅clarante d茅cline la qualit茅 de propri茅taire b茅n茅ficiaire, sauf dans la mesure d鈥檜n int茅r锚t p茅cuniaire.
Mary Lynne Hedley, Direktorin von Eli Lilly & Co. (LLY), meldete am 18.08.2025 eine Transaktion, bei der Aktien im Rahmen der Director-Deferral-Vereinbarungen des Unternehmens erworben wurden. Die Meldung weist einen Erwerb (Code A) von 14.206 Einheiten zu einem gemeldeten Preis von $698.05 aus. Nach der Transaktion werden 1,986.78 Aktien als wirtschaftlich gehalten angegeben; die Eigent眉merschaft ist gegebenenfalls als direkt und indirekt (durch Trust) ausgewiesen. In der Meldung hei脽t es, dass die Aktien statt Barverg眉tung als Aktieneinheiten im Rahmen des Lilly Directors-Deferral Plan aufgeschoben wurden und nach dem Ausscheiden der meldenden Person aus dem Unternehmen in Stammaktien umgewandelt werden. Die meldende Person verneint die wirtschaftliche Eigent眉merschaft, soweit nicht ein pecuni盲rer Anspruch besteht.
FAQ
What transaction did Mary Lynne Hedley report on Form 4 for LLY?
How many LLY shares did the filing show as beneficially owned after the transaction?
Were the acquired units immediately settled into shares?
Does the reporting person claim full beneficial ownership of the reported securities?
Was this Form 4 filed individually or jointly?
